Gobert Geoffrey N, McManus Donald P
Molecular Parasitology Laboratory, Australian Centre for International and Tropical Health and Nutrition, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia.
Parasitol Int. 2005 Jun;54(2):101-7. doi: 10.1016/j.parint.2005.02.004. Epub 2005 Apr 11.
Paramyosin was first identified as a structural component of invertebrate muscle. Analysis of crude, native, adult schistosome worm preparations identified a highly immunogenic protein which was later identified as paramyosin. Early vaccination/challenge studies with native paramyosin produced encouraging levels of protective efficacy against schistosomes, which led to the question as to how a sub-tegumental (muscular) protein could provide a target for vaccine-mediated immunological attack. Immunolocalisation studies of schistosomes confirmed the presence of paramyosin within the post-acetabular glands of cercariae and on the tegumental surface of lung schistosomula. Here we present an update on the more recent research on paramyosin in parasitic worms that has focused primarily in two directions: (i) further testing of the vaccine potency of paramyosin against schistosomes and other parasitic worms; and (ii) characterisation of the protein at the molecular and biochemical levels.
副肌球蛋白最初被鉴定为无脊椎动物肌肉的一种结构成分。对粗制的、天然的成年血吸虫虫体制剂进行分析,鉴定出一种高度免疫原性的蛋白质,后来被确定为副肌球蛋白。早期用天然副肌球蛋白进行的疫苗接种/攻毒研究产生了令人鼓舞的针对血吸虫的保护效力水平,这引发了一个问题,即一种皮层下(肌肉)蛋白如何能成为疫苗介导的免疫攻击的靶点。血吸虫的免疫定位研究证实,尾蚴的髋臼后腺和肺期血吸虫童虫的体表存在副肌球蛋白。在此,我们介绍关于寄生虫中副肌球蛋白的最新研究进展,这些研究主要集中在两个方向:(i)进一步测试副肌球蛋白针对血吸虫和其他寄生虫的疫苗效力;(ii)在分子和生化水平上对该蛋白进行表征。